Your browser doesn't support javascript.
loading
Molecular dynamics simulations of plutonium binding and its decorporation from the binding-cleft of human serum transferrin.
Mishra, Lokpati; Sundararajan, Mahesh; Bandyopadhyay, Tusar.
Afiliação
  • Mishra L; Radiation Safety Systems Division, Bhabha Atomic Research Centre, Mumbai, 400 085, India.
  • Sundararajan M; Homi Bhabha National Institute, Mumbai, 400094, India.
  • Bandyopadhyay T; Theoretical Chemistry Section, Bhabha Atomic Research Centre, Mumbai, 400 085, India.
J Biol Inorg Chem ; 25(2): 213-231, 2020 03.
Article em En | MEDLINE | ID: mdl-31980924
ABSTRACT
The possibility of plutonium (Pu) intake by radiation workers can not be ruled out. Transportation of Pu(IV) to various organs/cells is mainly carried through iron-carrying protein, serum transferrin (sTf), by receptor-mediated endocytosis. Understanding the Pu-sTf interaction is a primary step toward future design of its decorporating agents. We report MD simulations of Pu(IV) binding with sTf and look out for its decorporation at extracellular pH using suitable ligands. MD simulations were carried out in polarizable water environment at different protonation states of the protein. Results unravel the binding motif of Pu(IV) (1) sTf binds the ion in closed conformation at extracellular serum pH with carbonate as synergistic anions, (2) change in protonation state of dilysine (K206 and K296)-trigger and that of the carbonate ion at acidic endosomal pH is found to cause conformational changes of protein, conducive for the heavy ion to be released, although; (3) strong electrostatic interaction between D63 in the binding-cleft and Pu(IV) is found not to ever set free the ion. In an endeavour to decorporate Pu(IV), fragmented molecular form of hydroxypyridinone (HOPO) and catechol (CAM)-based ligands are docked at the binding site (BS) of the protein and metadynamics simulations are conducted. Pu(IV) binding at BS is found to be so strong that it was not detached from BS with the docked HOPO. However, for the identical set of simulation parameters, CAM is found to facilitate dislodging the heavy ion from the protein's binding influence. Differential behaviour of the two chelators is further explored. Fragmented molecular form of hydroxy-pyridinone (HOPO) and catecholamide (CAM) ligands were docked at the binding-site (BS) of human serum transferrin (sTf) to explore their feasibility as plausible Pu(IV) decorporating agents by employing metadynamics method. CAM was found to dislodge Pu from the sTf BS, while HOPO could not.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transferrina / Plutônio / Simulação de Dinâmica Molecular Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transferrina / Plutônio / Simulação de Dinâmica Molecular Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article